Phase 1 Trial for Triple-Negative Breast Cancer Vaccine Begins
- EXEC
- 11/01/2022
Cleveland Clinic researchers along with Anixa Biosciences have initiated a phase 1 clinical trial to test a vaccine intended to prevent triple-negative breast cancers (TNBC). This trial is a first...
READ MORE